Home > Press > Livingston Securities “Healthcare Investment Series” Webinar Covers Emerging Models for Pharma Exits and Deals
Livingston Securities (www.livingstonsecurities.com) held their first of a series of webinars covering innovation and dealmaking trends in healthcare and life sciences on June 25, 2009. Participants in the Livingston Securities "627 Club" webinars gain important insights into investment and business opportunities in nanotechnology-focused companies across multiple sectors. Healthcare and Life Sciences have been of particular interest to investors in recent months, and these webinars will continue over the summer leading up to the 2nd annual Livingston Securities Healthcare Advanced and Nanotechnology Investor Summit on September 24, 2009 in New York City.
Livingston Securities “Healthcare Investment Series” Webinar Covers Emerging Models for Pharma Exits and Deals
New York, NY | Posted on July 7th, 2009
The Livingston Securities Healthcare Webinar featured panelists from venture capital, private equity, pharmaceutical executives, advisors to the Obama administration, startups and emerging public companies, all discussing the current status of healthcare and life science investments, along with emerging models for M&A and partnerships.
The webinar was chaired by Dr. Mostafa Analoui, Head of Healthcare & Life Sciences for the Livingston Group of Companies . Panelists included Dr. David Collier, Managing Director of CMEA Capital, Dr. Michael Nowak, Managing Director at Yorkville Advisors, Dr. Gil Omenn, Director of the Center for Computational Medicine & Biology at University of Michigan and former President of the American Association for the Advancement of Science, Dr. Michael Krams, Vice President of Wyeth, Dr. Eugene Seymour, CEO of NanoViricides and Mr. Rodney Brown, CEO of PharmaNova.
Key topics included the current state of VC funding for healthcare and life science companies, impact of the recent credit crunch and lack of IPOs on VC-backed companies, as well as future directions for creative financing and deal making. Private equity strategies for mergers and acquisitions were presented by a number of PE firms in healthcare. Other discussions included plans to achieve universal health care and the impact on cost and pricing, and the impact on venture investment in research & development, and innovative methods for design and execution of clinical trials. CEOs representing early stage public and private companies described their business strategies for financial viability and innovative models for collaborations and product development.
Livingston Securities will hold its 2nd webinar covering healthcare investment trends on Monday, July 27, 2009. For details please contact or visit our website at www.livingstonsecurities.com.
About Livingston Securities
Livingston Securities is dedicated to providing corporate finance and strategic advisory services to corporate clients and sales, trading and related services to institutional investors and high net worth individuals who focus on disruptive technologies and their impact on healthcare, energy, infrastructure and other leading sectors of the American and global economy. Our goal is to provide a unique perspective and expertise on investments in nanotechnology and in companies that are commercializing and/or impacted by scientific advances in the emerging field of nanotechnology.
For more information, please click here
For Livingston Securities
Steven Wright-Mark, 212-677-8700 ext. 29
Copyright © Business Wire 2009
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Nanoliposomes Help Efforts to Cure Bacterial Infections January 27th, 2015
Stomach acid-powered micromotors get their first test in a living animal January 27th, 2015
Engineering self-assembling amyloid fibers January 26th, 2015
Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer January 26th, 2015
Spider electro-combs its sticky nano-filaments January 28th, 2015
JPK opens new expanded offices in Berlin to meet the growing demand for products worldwide January 28th, 2015
The laser pulse that gets shorter all by itself: Ultrashort laser pulses have become an indispensable tool for atomic and molecular research; A new technology makes creating short infrared pulses easy and cheap January 27th, 2015
New pathway to valleytronics January 27th, 2015
Pittcon News: Renishaw adds to the comprehensive imaging options available with its inVia confocal Raman microscope January 27th, 2015
Nanometrics to Present at the Stifel 2015 Technology, Internet and Media Conference January 27th, 2015
Toyocolor to Launch New Carbon Nanotube Materials at nano tech 2015 January 24th, 2015
NANOPOSTER 2015 - 5th Virtual Nanotechnology Conference - call for abstracts January 24th, 2015